Statistics
Publications
5
Citations
142
H-Index
5
Active since
2004
J. B. Orr is an author at GlaxoSmithKline (United States) specializing in oncology, medicine, and mitotic spindle inhibitors.
Publications per year
2004–2005
5
5
Phase I trial of novel kinesin spindle protein (KSP) inhibitor SB-715992 IV Q 21 days
Q. Chu, Kyle D. Holen, Eric K. Rowinsky et al. · Journal of Clinical Oncology · 2004 · 30 citations
Medicine, Oncology, Pharmacology +15
1–5 of 5